Background: Increased psychophysiological reactivity is a hallmark intermediate phenotype of posttraumatic stress disorder (PTSD). Individuals with PTSD exhibit greater skin conductance (SC) responses to trauma scripts than trauma survivors without PTSD. However, trauma scripts require time for development and cannot be easily used in a single visit. Thus, there is a need for a low-cost, easy-to-use, SC recording protocol for PTSD assessment.
INTRODUCTION
Posttraumatic stress disorder (PTSD) is a heterogeneous psychiatric disorder characterized by reexperiencing, avoidance/numbing, and hyperarousal symptoms (Kessler et al., 1995) . Increased psychophysiological arousal driven by the activation of the autonomic nervous system is a hallmark observation in PTSD (Michopoulos, Norrholm, Abbreviations: ANOVA, analysis of variance; BP, blood pressure; GCS, Glasgow Coma Scale; HR, heart rate; PDS, PTSD Diagnostic Scale; PSS, PTSD Symptom Scale; PTSD, posttraumatic stress disorder; ROC, receiver operating characteristic curve; RDoC, Research Domain Criteria; RR, respiration rate; SC, skin conductance; SCL, SC level; SCR, SC response; SEM, standard error of the mean; STI, standard trauma interview & Jovanovic, 2015) . Outputs of autonomic activation, including heart rate (HR), blood pressure (BP), skin conductance (SC), and respiration rate (RR) are all heightened in individuals with PTSD. Therefore using physiological data, such as HR and SC, offers the potential for quantitative objective assessment of physiological reactivity related to PTSD symptoms. One of the earliest methods using trauma-related stimuli to evoke physiological responses was based on a script-driven imagery procedure developed by Lang et al. (1978) to study phobias. In this method, the participant describes in detail an experienced traumatic event, which is then transcribed and played back to the individual while physiological responses are recorded (Pitman et al., 1987) . This method has been used in many different combat and civilian PTSD (Pitman et al., 1987; Shalev, Orr, & Pitman, 1993) , as well as with women who were sexually abused in childhood (Orr et al., 1997 ). Among the above-mentioned traumatized populations, those with a diagnosis of PTSD exhibit a stronger HR and SC response to scripts than non-PTSD trauma survivors. In 1998, Keane et al. (1998) conducted the largest script-driven imagery study to date, with almost 1,500 veterans, to look at the utility of psychophysiological measures in diagnosing PTSD. The study concluded that psychophysiological data provided useful and objective assessment of physiological reactivity associated with symptoms of the disorder. However, the specificity for PTSD was not very high, indicating that other factors, such as multiple traumas (McTeague et al., 2010) or high dissociation (Griffin, Resick, & Mechanic, 1997) , may be influencing psychophysiological responses. A recent meta-analysis of these early studies confirmed that psychophysiological responses to trauma scripts were predictive of PTSD diagnosis and were stable across time (Bauer et al., 2013) . Finally, both HR and SC show decreased responding after prolonged exposure therapy for PTSD, providing potential objective measures of treatment response (Wangelin & Tuerk, 2015) .
While these data suggest that PTSD can be characterized by psychophysiological reactivity, script-driven imagery methods were developed as experimental protocols and can be burdensome for clinicians, because they entail the development of the trauma scripts over at least two visits and presentation along with neutral scripts.
Most studies have used large and elaborate psychophysiological data acquisition equipment that requires dedicated space, specialized training, and substantial financial investment. In addition, the methodology has varied across studies, as some studies use multiple trauma scripts, while others use a shortened version. Efforts are currently underway to standardize these methods as common data elements and reduce burden in order to promote the generation of widespread and robust data collection in the same manner (e.g., PhenX Toolkit, www.phenyxtoolkit.org). A novel paradigm that builds on the history of script-driven imagery but is adapted to be used in clinical settings is recording psychophysiological reactivity during a trauma interview. SC or HR can be recorded continuously during a trauma interview using mobile applications on smartphones and tablets. A recent study that recorded HR while the patient talked about their trauma showed that severity of PTSD symptoms significantly predicted changes in HR, even after controlling for the effects of speech (Nachar, Guay, BeaulieuPrevost, & Marchand, 2013) . The importance of this aforementioned study is in the validation of psychophysiological measurements while discussing trauma. In contrast to earlier script-driven imagery, this approach can be easily disseminated in the clinic since a script does not have to be developed and played back to the patient. Such psychophysiological measures can make a seminal contribution to the National Institutes of Mental Health Research Domain Criteria (RDoC) initiative to include biological measures in assessments of mental illness (Miller, Rockstroh, Hamilton, & Yee, 2016; Morris, Vaidyanathan, & Cuthbert, 2015) . The measures can both indicate treatment targets and track clinical outcomes in an objective manner (Wangelin & Tuerk, 2015) .
The current study aimed to assess the ability of a low-cost, easy-touse, SC recording device (eSense) to detect differences in SC response to a standardized trauma interview (STI) between trauma-exposed individuals with and without PTSD. In addition, we hypothesized that concurrent PTSD symptom severity would be associated with SC reactivity. The validation of a cost-and time-effective method to capture physiological indices that can be easily obtained in most clinical and research settings may prove beneficial in the diagnosis and treatment of PTSD.
METHODS

Subjects
Study participants (n = 63) were recruited from the trauma center of 
Measures
The PTSD Diagnostic Scale (PDS) and an STI were used during baseline assessment in the trauma center to determine lifetime trauma history (Foa & Rothbaum, 1998; Rothbaum et al., 1992) . The STI was repeated 1 year later in a follow-up session, and the current paper only presents SC data collected during the follow-up visit. The STI contains 21 questions that query details about the trauma (for example: "What time of day did it happen?", "How long did this event last?", "Did you see other people's injury or death?"). The PhenX Toolkit lists all questions used in the STI at https://www.phenxtoolkit.org/index.php?pageLink = browse.protocoldetails&id = 630901. Current PTSD diagnosis and symptoms were measured by trained interviewers at the 1-year follow-up assessment using the previously validated PTSD Symptom Scale (PSS) (Foa, Riggs, Dancu, & Rothbaum, 1993) . The PSS is a psychometrically valid 17-item self-report scale assessing PTSD symptoms over the past 2 weeks (Foa & Tolin, 2000; Schwartz et al., 2005) . A PTSD diagnosis (scored as 0 or 1) was based on DSM-IV criteria, if participants met at least one re-experiencing symptom, three avoidance and/or numbing symptoms, two hyperarousal symptoms, and if the duration of symptoms was greater than one month (Falsetti, Resnick, Resick, & Kilpatrick, 1993) . The interview version of the PSS has been validated with clinician administered instruments and has been used previously to assess PTSD diagnosis (Jovanovic et al., 2010) . For a continuous measure of PTSD symptom total, we F I G U R E 1 Mobile SC assessment using eSense device and iPad summed the PSS items as previously described (Gillespie et al., 2009 ).
Similarly, we computed continuous measures for sub-clusters of symptoms, including re-experiencing, avoidance and hyperarousal symptom clusters. Inter-rater reliability was greater than 97% for all administered measures. All data were captured and managed using REDCap electronic data capture tools hosted by Emory University (Harris et al., 2009 ).
Mobile SC assessment
SC was assessed using the eSense SC system (Mindfield Biosystems, Inc., Berlin, Germany) on an iPad (iOS10). The eSense software was downloaded to the iPad and two finger electrodes were attached to the middle and index finger with Velcro straps. The electrodes were connected to the iPad using the audio connection input. In order to ensure good contact with the skin, isotonic paste was added to the electrodes prior to attaching to the fingers. eSense acquired data at a sampling rate of 10 Hz and the data were exported via email using csv files. Prior to using eSense in the current clinical assessment for PTSD, the method was tested as a proof of concept by comparing SC level (SCL) data collected by eSense to SCL collected concurrently in the same individual using a Biopac system (Biopac Systems, MP150 for Windows, Goleta, CA), with data sampled at 1000 Hz. Briefly, data were collected from a healthy volunteer (independent from current study sample) during a stressful arithmetic task with two isotonic gel-filled electrodes on one hand connected to eSense and electrodes on the other hand connected to Biopac. The electrodes and gel used in the test case were identical to the ones used in the clinical assessment study. The data were highly correlated, r = 0.94, P < .001. In the clinical assessment part of the current study, electrodes were attached to the fingers of the participant's nondominant hand during administration of the STI (Fig. 1) . Baseline SCL was recorded at the beginning of our standardized assessment during a 2-min rest period, immediately followed by the STI. SC response (SCR) was calculated by subtracting the SCL at the end of the baseline recording (average of the last 30 s of the 2-min period) from the maximum SCL value during the STI. 
TA B L E 1 Mean
Statistics
The data were analyzed using SPSS (v.24) and were summarized as mean ± standard error of the mean (SEM). The level was set at P ≤ .05 for statistical significance. The effects of PTSD diagnosis on SCL during the STI were analyzed using separate 2 × 2 analysis of variance (ANOVA) with PTSD diagnosis as the between-subjects factor, and condition (baseline vs. STI) as the within-subjects factor. Pearson's correlations were used to summarize the relationship between SCR and PTSD symptom severity, as well as with PTSD symptom subclusters. Linear regression was used to determine whether peak SCR to the STI was predictive of continuous PTSD symptom severity, and logistic regression was used to determine whether peak SCR predicted categorical PTSD diagnosis. Finally, receiver operating characteristic curve (ROC) was used to evaluate the clinical performance for detection of PTSD by SCR. The areas under the curve and 95% confidence intervals were determined to test the accuracy of SCR for predicting PTSD diagnosis.
RESULTS
Sociodemographics
The mean ± SEM age in the overall sample was 34.8 ± 1.82 and participants had experienced 2.58 ± 0.23 traumas in their lifetime.
Traumas experienced and queried in relationship to current PTSD symptoms included: nonsexual assaults (9.5%), motor vehicle collisions (50.8%), sexual assaults (7.9%), motorcycle accidents (14.3%), and other (17.5%). The mean ± SEM time since index trauma exposure in the overall sample was 386 ± 3.14 days. The participants were primarily African American, with an average monthly income of >$1000.
Men and women were equally represented in the current study. Of the 63 participants, 15 met diagnostic criteria for PTSD. Table 1 shows the demographic and trauma history information across participants with F I G U R E 2 (A) Mean ± SEM skin conductance level (SCL, microSiemems, S) at baseline and at maximum levels during trauma reminder broken down by PTSD diagnosis. (B) The increase in SCR to STI in PTSD+ and PTSD− individuals. (C) Scatter plot of PTSD symptoms (PSS total score) and SCR to STI. ***P < .001, **P < .01
and without PTSD. There were no significant differences in these factors between PTSD+ and PTSD− groups (all P's > .05).
PTSD diagnosis and SCR to trauma reminder
SCL was significantly higher during the STI compared to baseline (F 1,61 = 67.8, P < .001). While there was no main effect of PTSD diagnosis on average SCL (F 1,61 = 3.75, P = .057), there was a significant condition by PTSD interaction (F 1,61 = 8.25, P = .006). Individuals with PTSD showed significantly higher peaks in SCL during the STI compared to individuals without PTSD ( Fig. 2A) . In addition, the SCR to the STI was significantly greater in those with PTSD compared to those without PTSD (F 1,61 = 8.25, P = .006; Fig. 2B ). This effect of PTSD remained significant after controlling for demographic variables, including age, sex, and trauma exposure (F 1,58 = 7.06, P = .01). Logistic regression using the SCR with PTSD diagnosis as the outcome showed an odds ratio of 1.76 (95% CI, 1.11-2.78), indicating that for each 1 s increase in SC change score in response to trauma challenge, there was a 76% greater odds of having a PTSD diagnosis. The AUC for the ROC curve analysis for SCR on PTSD diagnosis was 0.79 (P = .001), with 95% confidence intervals of 0.66 and 0.91.
PTSD symptom total and SCR to trauma reminder
PTSD symptom total was significantly correlated with SCR to the STI (r = 0.42, P = .001), Figure 2C . SCR during the STI was also significantly associated with symptom cluster subscales: intrusive (r = 0.36, P = .004), avoidance/numbing (r = 0.38, P = .002), and hyperarousal symptoms (r = 0.38, P = .002). Linear regression showed that the increase in SCR was significantly predictive of PTSD symptom total after controlling for covariates, including age, sex, and trauma exposure (b = 0.42, P = .001).
DISCUSSION
The current study found that changes in SC elicited by a standardized trauma interview were greater in individuals with PTSD compared to those without PTSD. There was also a significant positive correlation between SCR and PTSD symptoms. While SC has been shown in previous studies to be associated with PTSD symptoms (Orr et al., 1997; Pineles et al., 2013; Pitman et al., 1987; Shalev et al., 1993) , the current study is an important extension of previous work in three ways: (1) it used a low-cost mobile device to collect SC data, (2) the method can be easily disseminated in a wide variety of clinical and research settings, and (3) it used a standardized trauma interview in combination with psychophysiological assessment, which was developed as a common data element for PTSD in order to standardize PTSD measures across different settings.
Our data show that psychophysiological responses can be measured using low-cost and low-burden instruments, which are critical for the widespread dissemination of these objective measures to assess psychophysiological reactivity in those with PTSD. Importantly, we first tested this mobile method as a proof of concept by comparing individual results with state-of-the-art research equipment, Biopac Systems MP150 that we have used in our previous research (Glover et al., 2011; Rothbaum et al., 2014) . In addition, we validated the use of a standardized psychophysiological trauma challenge measure from the PhenX Toolkit, which is available for download. While the STI has been validated clinically (Rothbaum et al., 1992) , this is the first time it has been used as a psychophysiological challenge task. Because To our knowledge, the current study is the first published account of using this mobile technology to assess psychophysiological reactivity in PTSD, thereby providing important proof of concept. While previous data show that SC measurement may be more difficult to assess in African American individuals (Johnson & Landon, 1965; Lieblich, Kugelmass, & Ben-Shakhar, 1973 ), race did not appear to affect either SCL or SCR in the current study (P = .22 and P = .24, respectively).
Replication studies in larger sample sizes must be undertaken to assess the utility and generalizability of this approach alongside other measures of autonomic function, and allow for further characterization of factors that might influence PTSD symptoms, as SCR alone had a specificity of 79% for PTSD. Thus, a few individuals with low PTSD symptoms demonstrated high SCR to trauma reminders (Fig. 2C ).
These replications would also address one of the limitations of the current study; specifically, that it includes a relatively small proportion of PTSD+ cases. However, by also assessing the relationship between SCR and continuous PTSD symptoms, we have included a wider range of pathology and a more dimensional approach in our analyses. A further limitation of the current study was that it was based on DSM-IV criteria for PTSD (APA, 2000) , given that it was started prior to the change to DSM-5. Another limitation that should be addressed in future validation studies is that SC was collected during the interview and could have been impacted by speech.
While a previous study of HR did not show detrimental impact of speech patterns, SC may be more easily affected by changes in respiration. A validation study using an imagery component after the interview might minimize this effect. Further, it is possible that those with higher symptoms would have more disrupted speech patterns. Future studies might separate these mechanistic effects; in the interim, the utility of the measure in clinical settings appears very promising.
In summary, the current study presents a simple and novel method of assessing physiological reactivity to trauma-related cues using a mobile device to capture SC responses without the need of specialized training. While this method is not intended to replace clinician or patient symptom ratings, it can be used in conjunction with such ratings to provide a biological measure of symptom severity that is easily measured and readily accessible.
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